Skip to main content

Table 1 Design of the [105Ag]AgNP biokinetics study and the auxiliary studies after intravenous injection, intratracheal instillation, and intra-oral instillation (gavage) of [110mAg]AgNO3

From: Quantitative biokinetics over a 28 day period of freshly generated, pristine, 20 nm silver nanoparticle aerosols in healthy adult rats after a single 1½-hour inhalation exposure

Female, healthy, adult WKY rats, 8–10 weeks old

dissection time-points for biodistribution analyses

  

0.75 h/1sta

0.75 h/2ndb

4 h

24 h/1st

24 h/2ndb

7d

28d

[105Ag]AgNP Inhalation, 1½ -hour exposure

# of rats

4

4

4

4

4

4

4

Intratravenous injection of soluble [110mAg]AgNO3

# of rats

   

4

 

4

 

Intratracheal instillation of soluble [110mAg]AgNO3

# of rats

   

4

 

4

 

Oral instillation (gavage) of soluble [110mAg]AgNO3

# of rats

   

4

 

4

 
  1. a Note: rats were exsanguinated and dissected immediately after the 1.5-h exposure; “0.75 h” represents the mean time-point of the 1.5-h exposure
  2. b The measurements at 0.75 h and 24 h p.e. were repeated using a second group of rats, respectively, in order to test data reproducibility during the rapidly changing biokinetics directly after inhalation
  3. Study design of the [105Ag]AgNP biokinetics study in adult rats from immediately after inhalation up to 28 days p.e. The number of rats at each dissection time-point is given. Auxiliary biokinetics studies were performed after intratracheal instillation, intravenous injection, and oral instillation (gavage) of [110mAg]AgNO3 solutions at two dissection time points 24 h and 7 days p.e.